TradingKey

mehr Informationen über QuidelOrtho Corp Unternehmen

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Unternehmensinformationen

BörsenkürzelQDEL

Name des UnternehmensQuidelOrtho Corp

IPO-datumFeb 01, 1991

Gegründet am2021

CEOMr. Brian J. Blaser

Anzahl der mitarbeiter6600

WertpapierartOrdinary Share

GeschäftsjahresendeFeb 01

Addresse9975 Summers Ridge Road

StadtSAN DIEGO

BörseNASDAQ Global Select Consolidated

LandUnited States of America

Postleitzahl92121

Telefon18585521100

Websitehttps://www.quidelortho.com/

BörsenkürzelQDEL

IPO-datumFeb 01, 1991

Gegründet am2021

Führungskräfte

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

11.45K

--

Mr. John R. Chiminski

Independent Director

2.52K

--

Sergio Gadaleta

Senior Vice President - Clinical and Regulatory Affairs

--

Devon Burek

Senior Vice President - Global Quality

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9.68%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+7.29%

Mr. Joseph M. Busky

Chief Financial Officer

33.58K

+75.18%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

29.21K

+25.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+35.98%

Ms. Ann D. Rhoads

Independent Director

14.27K

+75.49%

Umsatzaufteilung

Währung: USDAktualisiert: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

Nach RegionUSD

Name

Umsatz

Anteil

North America

406.70M

58.70%

Other

122.20M

17.64%

EMEA

88.90M

12.83%

China

75.00M

10.83%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Labs

373.10M

53.85%

Point-of-Care

170.80M

24.65%

Immunohematology

128.50M

18.55%

Donor Screening

12.80M

1.85%

Molecular Diagnostic Solutions

7.60M

1.10%

Aktionärsstatistik

Aktualisiert: Wed, Jul 16

Aktionäre

Aktionärstypen

Aktionäre

Anteil

T. Rowe Price Investment Management, Inc.

16.93%

The Vanguard Group, Inc.

11.53%

BlackRock Institutional Trust Company, N.A.

11.17%

Rubric Capital Management LP

6.86%

Invesco Advisers, Inc.

5.33%

Other

48.19%

Aktionäre

Anteil

T. Rowe Price Investment Management, Inc.

16.93%

The Vanguard Group, Inc.

11.53%

BlackRock Institutional Trust Company, N.A.

11.17%

Rubric Capital Management LP

6.86%

Invesco Advisers, Inc.

5.33%

Other

48.19%

Aktionärstypen

Aktionäre

Anteil

Investment Advisor

60.73%

Investment Advisor/Hedge Fund

33.26%

Hedge Fund

15.22%

Research Firm

2.15%

Pension Fund

1.27%

Sovereign Wealth Fund

1.18%

Individual Investor

0.92%

Bank and Trust

0.68%

Family Office

0.36%

Institutionelle Beteiligung

Aktualisiert: Tue, Jul 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q2

682

78.07M

115.45%

-20.91M

2025Q1

726

76.59M

113.26%

-21.60M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

2023Q2

860

68.99M

103.61%

-6.94M

2023Q1

894

68.68M

103.29%

-6.80M

Aktionärsaktivitäten

Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

T. Rowe Price Investment Management, Inc.

11.45M

16.93%

+208.36K

+1.85%

Mar 31, 2025

The Vanguard Group, Inc.

6.72M

9.94%

-77.05K

-1.13%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.55M

11.17%

-233.81K

-3.00%

Mar 31, 2025

Rubric Capital Management LP

6.14M

9.08%

+590.00K

+10.63%

Mar 31, 2025

Invesco Advisers, Inc.

3.60M

5.33%

+375.44K

+11.64%

Mar 31, 2025

AQR Capital Management, LLC

2.66M

3.93%

+1.85M

+230.30%

Mar 31, 2025

State Street Global Advisors (US)

2.19M

3.24%

-83.38K

-3.67%

Mar 31, 2025

ArrowMark Colorado Holdings, LLC

1.89M

2.8%

-84.96K

-4.30%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.82M

2.69%

+600.34K

+49.32%

Mar 31, 2025

American Century Investment Management, Inc.

1.59M

2.35%

+473.09K

+42.41%

Mar 31, 2025

Verbundene ETFs

Aktualisiert: 2 hours ago

Name

Anteil

SPDR S&P Health Care Equipment ETF

1.7%

Invesco S&P SmallCap Health Care ETF

1.37%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.63%

Ballast Small/Mid Cap ETF

0.41%

iShares S&P Small-Cap 600 Value ETF

0.3%

WisdomTree US SmallCap Quality Growth Fund

0.3%

SPDR S&P 600 Small Cap Value ETF

0.29%

Avantis US Small Cap Value ETF

0.28%

JPMorgan Fundamental Data Science Mid Core ETF

0.22%

iShares U.S. Medical Devices ETF

0.22%

SPDR S&P Health Care Equipment ETF

Anteil1.7%

Invesco S&P SmallCap Health Care ETF

Anteil1.37%

First Trust Nasdaq Lux Digi Health Solutions ETF

Anteil0.63%

Ballast Small/Mid Cap ETF

Anteil0.41%

iShares S&P Small-Cap 600 Value ETF

Anteil0.3%

WisdomTree US SmallCap Quality Growth Fund

Anteil0.3%

SPDR S&P 600 Small Cap Value ETF

Anteil0.29%

Avantis US Small Cap Value ETF

Anteil0.28%

JPMorgan Fundamental Data Science Mid Core ETF

Anteil0.22%

iShares U.S. Medical Devices ETF

Anteil0.22%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split

Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten

QuidelOrtho Corp

22.810USD

QuidelOrtho Corp

22.810

Übersicht

Unternehmen

Finanzen